Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 5Head & Neck 3Genitourinary 3Gastrointestinal 3Dermatologic 3Breast 2Other solid neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 16Triple Negative Breast Neoplasms 11Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 6Urinary Bladder Neoplasms 4Carcinoma, Renal Cell 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Neoplasm Metastasis 3Melanoma 3Head and Neck Neoplasms 3Carcinoma, Merkel Cell 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Neoplasm, Residual 1Mesothelioma, Malignant 1Gastrointestinal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Adrenocortical Carcinoma 1

Interventions

pembrolizumab 14Gemcitabine 8Docetaxel 7Nivolumab 6durvalumab 5Cyclophosphamide 5130-nm albumin-bound paclitaxel 5atezolizumab 4Magnetic Resonance Spectroscopy 4Irinotecan 4sargramostim 3aldesleukin 3Specimen Handling 3Radiotherapy 3Paclitaxel 3Ipilimumab 3Fulvestrant 3Cisplatin 3Carboplatin 3venetoclax 2temsirolimus 2talazoparib 2spartalizumab 2olaparib 2liposomal doxorubicin 2fludarabine phosphate 2cabozantinib 2budigalimab 2avelumab 2Vinorelbine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × avelumab × Breast × Clear all
NCT02554812 2024-07-30

JAVELIN Medley

Pfizer

Phase 1/2 Terminated
409 enrolled 108 charts
BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Jules Bordet Institute

Phase 2 Unknown
441 enrolled
BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡